Any interested participants may dial into the Biomagnetics
Diagnostics Corporation, through its wholly owned subsidiary, Biospectrum Technologies, Inc.
Over the past few months, we have communicated to our shareholders and business community regarding specific activities Biomagnetics
has undertaken to increase share value and obtain additional capital required to bring our products to market without causing further stock dilution.
Expected Department of Defense payoff areas for the BioMagnetICs
program include rapid, robust, hand-held bio-detection devices with multi-analyte capability and high sensitivity.
Clayton Hardman, CEO of Biomagnetics
, said: "Prior to beginning deliveries of biofuel under the currently signed supply contract, but immediately upon closing of this acquisition, we will be filing several Chinese, US and international patents on this unique formulation of biofuels.
Magnets aren't magic,'' says BarbaraSteele,a Wirral-born BioMagnetic
consultant, now working in North Wales.
Global Bio Energy will license the PVA technology to this Chinese entity with Biomagnetics
Diagnostics Corporations' fees to be used by the company to complete development of and begin manufacturing of the integrated optical biosensor device, developed in conjunction with Los Alamos national laboratory.
Bionas Bio-Rad Laboratories Bioscale Biosite Biosurfit BioTray Biotrove BioVitesse Boehringer Ingelheim Boston Microfluidics California Institute of Regenerative Medicine (CIRM) Caliper Life Sciences Cambridge Biomagnetics
Capilix CapitalBio Corporation CEA Laboratory of Electronics and Information Technologies (LETI) Cellanyx Cellasic Cellectricon Cellix Celula Center for Devices and Radiological Health (CDRH) Cepheid Cetoni Claros Diagnostics ClonDiag Corium International Crospon Cyclofluidic Cynvenio CYTOO Cell Architects
Clayton Hardman, President of Biomagnetics
states, "During the past few months Biomagnetics
has been quiet while we were trying to raise the necessary capital to complete the engineering and bring our advanced Integrated Optical Bio Sensor to market.
Sample Preparation Test Systems Biomagnetics
Diagnostics Corporation BlackBio S.
As part of the transaction, Biomagnetics
will receive common shares in the new company, while Biomagnetics
is also expected to receive a significant amount of funding at the closing of the transaction.
Not only will the device provide a qualitative tuberculosis diagnosis in a fraction of the time of other testing protocols it will also provide these results at only a fraction of the cost, commented Clayton Hardman, CEO of Biomagnetics